Norway: Nordic Nanovector merging with APIM Therapeutics

Oslo-listed Nordic Nanovector, a developer of therapies to address major unmet medical needs and advance cancer care, and all shareholders of APIM Therapeutics, a privately held, clinical-stage cancer-focused biotechnology company, have entered into a merger agreement to combine the companies in an all-stock transaction.  The agreement follows a review that Nordic Nanovector conducted, in conjunction…

You must be a HMI Subscriber to view this content.

Subscribe Now »